Zomedica Corp (ZOM)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 6,964,000 6,500,000 7,895,000 6,997,000
Cost of Revenue 2,298,000 2,093,000 2,347,000 1,937,000
Gross Profit 4,666,000 4,407,000 5,548,000 5,060,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 10,815,000 11,269,000 11,562,000 10,655,000
Operating Expenses 12,701,000 13,122,000 15,685,000 12,500,000
Operating Income -8,035,000 -64,548,000 -8,160,000 -7,440,000
Interest Expense 0 0 0 0
Income Before Tax -7,386,000 -63,866,000 -7,415,000 -6,724,000
Income Tax Expense 12,000 -57,000 -221,000 -27,000
Net Income -7,398,000 -63,809,000 -7,194,000 -6,697,000
Per Share
EPS -0.01 -0.07 -0.01 -0.01
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 27,285,000 25,186,000 18,930,000 4,133,123 0
Cost of Revenue 8,198,000 7,868,000 5,278,000 1,079,052 0
Gross Profit 19,087,000 17,318,000 13,652,000 3,054,071 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 46,848,000 43,166,000 32,997,000 22,749,080 6,011,985
Operating Expenses 70,140,000 48,910,000 35,575,000 24,428,068 14,055,876
Operating Income -51,053,000 -31,592,000 -21,923,000 -21,373,997 -16,764,978
Interest Expense 0 175,000 1,000 6,054 732
Income Before Tax -47,539,000 -35,860,000 -19,381,000 -20,716,224 16,911,784
Income Tax Expense -557,000 -1,331,000 -2,366,000 -2,333,054 0
Net Income -46,982,000 -34,529,000 -17,015,000 -18,383,170 16,911,784
Per Share
EPS -0.05 -0.04 -0.02 -0.02 0.05
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 7,021,000 12,952,000 27,399,000 194,952,208
Short Term Investments 64,332,000 77,545,000 87,693,000 0
Net Receivables 3,071,000 2,198,000 1,864,000 765,499
Inventory 5,058,000 5,123,000 2,746,000 2,847,985
Total Current Assets 81,773,000 99,882,000 123,501,000 200,407,506
Property Plant Equipment 26,200,000 25,294,000 9,166,000 2,525,356
Goodwill and Intangibles 98,094,000 116,944,000 105,778,000 76,807,325
Total Assets 207,360,000 253,197,000 279,610,000 280,399,293
Liabilities
Account Payables 1,929,000 7,668,000 6,698,000 3,225,348
Short Term Debt 523,000 916,000 1,282,000 414,695
Total Current Liabilities 9,331,000 9,032,000 7,811,000 4,339,700
Long Term Debt 1,291,000 1,814,000 1,097,000 964,191
Total Liabilities 11,696,000 13,180,000 12,218,000 9,513,950
Shareholders Equity
Retained Earnings -217,915,000 -170,933,000 -136,404,000 -119,391,398
Total Shareholders Equity 195,664,000 240,017,000 267,392,000 270,885,343
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 7,021,000 12,952,000 27,399,000 194,952,208 61,992
Short Term Investments 64,332,000 77,545,000 87,693,000 0 0
Net Receivables 3,071,000 2,198,000 1,864,000 765,499 0
Inventory 5,058,000 5,123,000 2,746,000 2,847,985 0
Total Current Assets 81,773,000 99,882,000 123,501,000 200,407,506 61,992
Property Plant Equipment 26,200,000 25,294,000 9,166,000 2,525,356 583
Goodwill and Intangibles 98,094,000 116,944,000 105,778,000 76,807,325 377
Total Assets 207,360,000 253,197,000 279,610,000 280,399,293 62,951
Liabilities
Account Payables 1,929,000 7,668,000 6,698,000 3,225,348 1,249
Short Term Debt 523,000 916,000 1,282,000 414,695 780,148
Total Current Liabilities 9,331,000 9,032,000 7,811,000 4,339,700 1,501
Long Term Debt 1,291,000 1,814,000 1,097,000 964,191 275
Total Liabilities 11,696,000 13,180,000 12,218,000 9,513,950 -1,227
Shareholders Equity
Retained Earnings -217,915,000 -170,933,000 -136,404,000 -119,391,398 0
Total Shareholders Equity 195,664,000 240,017,000 267,392,000 270,885,343 51,065,863
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -46,982,000 -34,529,000 -17,015,000 -18,383,170
Depreciation & Amortization 7,986,000 6,298,000 4,042,000 1,139,589
Stock Based Compensation 2,778,000 6,263,000 7,891,000 7,092,031
Change in Working Capital -1,071,000 19,000 -5,703,000 -3,875,793
Operating Cash Flow -23,630,000 -15,975,000 -11,670,000 -14,275,156
Investing Activities
Capital Expenditure -6,793,000 -11,339,000 -1,026,000 -526,174
Investments -5,212,000 -4,646,000 -1,026,000 -526,174
Investing Cash Flow 17,854,000 1,577,000 -155,880,000 -71,925,368
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 0 0 8,000 199,525,000
Dividends Paid 0 0 0 0
Financing Cash Flow -70,000 0 8,000 219,159,366
Summary
Free Cash Flow -30,423,000 -20,621,000 -12,696,000 -14,801,330
Net Change in Cash -5,931,000 -14,447,000 -167,553,000 132,960,505
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -46,982,000 -34,529,000 -17,015,000 -18,383,170 16,911,784
Depreciation & Amortization 7,986,000 6,298,000 4,042,000 1,139,589 305,914
Stock Based Compensation 2,778,000 6,263,000 7,891,000 7,092,031 1,656,184
Change in Working Capital -1,071,000 19,000 -5,703,000 -3,875,793 -1,715,983
Operating Cash Flow -23,630,000 -15,975,000 -11,670,000 -14,275,156 0
Investing Activities
Capital Expenditure -6,793,000 -11,339,000 -1,026,000 -526,174 20,400
Investments -5,212,000 -4,646,000 -1,026,000 -526,174 -14,850
Investing Cash Flow 17,854,000 1,577,000 -155,880,000 -71,925,368 1,005,719
Financing Activities
Debt Repayment 0 0 0 0 0
Common Stock Issued/Repurchased 0 0 8,000 199,525,000 56,496,283
Dividends Paid 0 0 0 0 0
Financing Cash Flow -70,000 0 8,000 219,159,366 76,714,761
Summary
Free Cash Flow -30,423,000 -20,621,000 -12,696,000 -14,801,330 20,400
Net Change in Cash -5,931,000 -14,447,000 -167,553,000 132,960,505 61,481,117